[Hong Kong, 4 March 2016]  Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.

Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare.   Mr Liu’s area of focus is commercialisation and M&A.  He has extensive experience in healthcare big data and healthcare technologies.

Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr  Ha Yung-kuen have also been re-appointed for another two-year term.

Related News

Delegation of Young Democratic Alliance for the Betterment and Progress of Hong Kong visits ASTRI

A group of nine committee members of the Young Democratic Alliance for the Betterment and Progress o ...

ASTRI and Cyberport partnership seeks to facilitate unleash great potential for AI and Blockchain start-ups

[17 July 2018, Hong Kong] Hong Kong Applied Science and Technology Research Institute (ASTRI) and Cy ...

Ms Mary Ng, Member of Canadian Parliament, visits ASTRI

Ms Mary Ng, Member of the Parliament of Canada, accompanied by Mr Jeff Nankivell, Consul General of ...

Correctional Services Department Visits ASTRI

A group of senior civil servants from the Hong Kong Correctional Services Department (CSD), and Elec ...

ASTRI partners with HKSTP and Molecular Hub in organising Blockchain Accelerator Programme for start-ups

ASTRI is partnering with the Hong Kong Science and Technology Parks Corporation (HKSTP) and Molecula ...